Evidence map›Paper›PMID 17329327›Full record

ArticleJournal of virology2007

Antiviral antibodies are necessary for control of simian immunodeficiency virus replication.

Christopher J Miller, Meritxell Genescà, Kristina Abel, David Montefiori, Donald Forthal, Kristen Bost, Jun Li, David Favre, Joseph M McCune

Abstract read
In one paragraph

Article in Journal of virology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. IgG Binding Characteristics of Rhesus Macaque FcγR.Journal of immunology (Baltimore, Md. : 1950) · 2016
    Article
  13. Article
  14. Article
  15. Effects of neutralizing antibodies on escape from CD8+ T-cell responses in HIV-1 infection.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2015
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Christopher J MillerCenter for Comparative Medicine, California National Primate Research Center, University of California, Davis, Davis, California 95616, USA. cjmiller@ucdavis.edu
Meritxell Genescà
Kristina Abel
David Montefiori
Donald Forthal
Kristen Bost
Jun Li
David Favre
Joseph M McCune

Funding

ZONA PELLUCIDA PEPTIDES AS IMMUNOCONTRACEPTIVE ANTIGENSP51RR000169 · NCRR · UNIVERSITY OF CALIFORNIA DAVIS · PI HYDE, DALLAS MELVIN · 1985 to 2011
$126.2M
Supplement to Mechanisms of Protection in Live-attenuated AIDS VaccinesP01AI066314 · NIAID · UNIVERSITY OF CALIFORNIA DAVIS · PI MILLER, CHRISTOPHER JAMES · 2005 to 2009
$8.5M
NIH Director's Pioneer Award (RMI)DP1OD000329 · OD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MCCUNE, JOSEPH M · 2004 to 2008
$4.2M
Novel Biological Activities of Anti-Viral AntibodyR01AI052039 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI FORTHAL, DONALD N · 2002 to 2006
$1.5M
NCRR NIH HHS U51 RR00169NIAID NIH HHS N01 AI030034NIAID NIH HHS P01 AI066314NIAID NIH HHS R01 AI052039NIAID NIH HHS R01 AI30034NIAID NIH HHS R01 AI 52039NIH HHS DP1 OD000329NIH HHS OD00329
6 · The paper itself

Abstract

To better define the role of B cells in the control of pathogenic simian immunodeficiency virus (SIV) replication, six rhesus monkeys were depleted of B cells by intravenous infusion of rituximab (anti-CD20) 28 days and 7 days before intravaginal SIVmac239 inoculation and every 21 days thereafter until AIDS developed. Although the blood and tissues were similarly depleted of B cells, anti-SIV immunoglobulin G (IgG) antibody responses were completely blocked in only three of the six animals. In all six animals, levels of viral RNA (vRNA) in plasma peaked at 2 weeks and declined by 4 weeks postinoculation (PI). However, the three animals prevented from making an anti-SIV antibody response had significantly higher plasma vRNA levels through 12 weeks PI (P = 0.012). The remaining three B-cell-depleted animals made moderate anti-SIV IgG antibody responses, maintained moderate plasma SIV loads, and showed an expected rate of disease progression, surviving to 24 weeks PI without developing AIDS. In contrast, all three of the B-cell-depleted animals prevented from making anti-SIV IgG responses developed AIDS by 16 weeks PI (P = 0.0001). These observations indicate that antiviral antibody responses are critical in maintaining effective control of SIV replication at early time points postinfection.

Indexed as

Virus ReplicationAnimalsAntibodies, MonoclonalAntibodies, Monoclonal, Murine-DerivedAntibodies, ViralBase SequenceB-LymphocytesFemaleImmunoglobulin GImmunologic FactorsLymphocyte DepletionMacaca mulattaMolecular Sequence DataReceptors, IgGRituximabRNA, ViralAntibodies, MonoclonalAntibodies, Monoclonal, Murine-DerivedAntibodies, ViralImmunoglobulin GImmunologic FactorsReceptors, IgGRituximabRNA, Viral

Identifiers

PMID17329327
PMCPMC1900210

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.